[1][2][3] DCVMN includes manufacturers in Brazil, China, Cuba, India, Indonesia, Mexico, South Africa and other low and middle income countries (LMICs).
[9] Members are developing and producing novel vaccines for illnesses including neglected tropical diseases:[11] rotavirus, Japanese encephalitis, pertussis,[12] haemophilus influenzae, hepatitis B,[13] hepatitis E, meningitis A,[3] cholera, poliovirus, human papillomavirus infection, dengue fever, Chikungunya virus and COVID-19.
[15][16] As of 2016, the timeline from a vaccine's first regulatory submission in its country of origin to its approval for use in Sub-Saharan Africa could take up to seven years.
This can involve governments in different countries, the World Health Organization (WHO), and United Nations agencies such as UNICEF.
[17][19][20] The Developing Countries Vaccine Manufacturers Network has received funding from the Bill & Melinda Gates Foundation.